| Description | DL-Propargylglycine HCl (DL-Propargyl Glycine HCl) is a potent irreversible inhibitor of cystathionine γ-cleaving enzyme and can be used in the study of heart failure. |
| Synonyms | DL-Propargyl Glycine HCl, DL-Propargyl Glycine hydrochloride |
| molecular weight | 149.58 |
| Molecular formula | C5H8ClNO2 |
| CAS | 16900-57-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | PBS (pH 7.2): 5 mg/mL (33.43 mM), Sonication is recommended. DMSO: 5 mg/mL (33.43 mM), Sonication is recommended. Ethanol: 20 mg/mL H2O: 5 mg/mL (33.43 mM), Sonication is recommended. DMF: 5 mg/mL (33.43 mM), Sonication is recommended. |
| References | 1. Daniel Paul Becker et al.Carborane hydroxamic acid matrix metalloproteinase agents for boron neutron capture therapy:WO2020252439A1. |